-
Diagnostics World | In a paper published last month in Nature Scientific Reports, authors validate Northstar Response, BillionToOne's novel tissue-free circulating tumor DNA (ctDNA) liquid biopsy test that enables physicians to monitor cancer treatment response in Stage III-IV cancers with a blood draw.
Mar 5, 2025
-
Diagnostics World | A transcontinental collaborative effort brought together 300 experts from 12 European countries and Canada to try and crack the genetic cause of thousands of unsolved rare disease cases. Through data-sharing and genetic reanalysis, this “coalition of the willing” has most recently succeeded in providing more than 500 patients with a long-awaited diagnosis—and peace of mind to unaffected family members about whether they carry the risk variant.
Mar 4, 2025
-
Diagnostics World | Dovetail Genomics announced its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis; Cellino announced its collaboration with Mass General Brigham’s Gene and Cell Therapy Institute (GCTI) to launch the world’s first hospital-based autologous induced pluripotent stem cell (iPSC) Foundry; and more.
Feb 27, 2025
-
Diagnostics World | A transcontinental collaborative effort brought together 300 experts from 12 European countries and Canada to try and crack the genetic cause of thousands of unsolved rare disease cases. Through data-sharing and genetic reanalysis, this “coalition of the willing” has most recently succeeded in providing more than 500 patients with a long-awaited diagnosis—and peace of mind to unaffected family members about whether they carry the risk variant.
Feb 26, 2025
-
Diagnostics World | Researchers at the University of Cambridge have developed washable and comfortable ‘smart pajamas’ to help monitor sleep disorders at home. The pajamas negate the need for sticky patches, monitoring equipment, or visiting sleep clinics for specialty tests.
Feb 20, 2025
-
Diagnostics World | Amid an industrywide shortage of workers and hospital capacity, a multimodal artificial intelligence (AI) platform providing real-time visibility into the clinical picture for patients is finding a national audience with health systems big and small who want to “make the right thing the easy thing to do” for their overburdened clinicians.
Feb 13, 2025
-
Diagnostics World | Two glycans are better than one when it comes to detecting pancreatic cancer that currently lacks a biomarker capable of accurately and reliably spotting the disease. The gold standard biomarker CA19-9, approved by the U.S. Food and Drug Administration (FDA) for monitoring response to treatment, correctly identifies only 44% of cases but the addition of CA199.STRA ramped that up to 71% while maintaining a low false positive rate in a recent case control study.
Feb 11, 2025
-
Diagnostics World | Physiological changes in the body driven by inflammation, as happens with inflammatory bowel disease (IBD) and rheumatoid arthritis, can be “easily and passively” measured with commercially available wearable devices, according to gastroenterologist Robert Hirten, M.D., associate professor of medicine and artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai.
Feb 5, 2025
-
Diagnostics World | Amid an industrywide shortage of workers and hospital capacity, a multimodal artificial intelligence (AI) platform providing real-time visibility into the clinical picture for patients is finding a national audience with health systems big and small who want to “make the right thing the easy thing to do” for their overburdened clinicians.
Feb 4, 2025